ENDRA Life Sciences Inc.
NDRA
$3.57
$0.1253.63%
| Weiss Ratings | NDRA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | NDRA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | NDRA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.81 | |||
| Price History | NDRA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -14.10% | |||
| 30-Day Total Return | -28.70% | |||
| 60-Day Total Return | -25.26% | |||
| 90-Day Total Return | -68.83% | |||
| Year to Date Total Return | -44.64% | |||
| 1-Year Total Return | -99.81% | |||
| 2-Year Total Return | -99.95% | |||
| 3-Year Total Return | -99.98% | |||
| 5-Year Total Return | -99.99% | |||
| 52-Week High % Change | -99.83% | |||
| 52-Week Low % Change | 9.21% | |||
| Price | NDRA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $2,004.98 | |||
| 52-Week Low Price | $3.15 | |||
| 52-Week Low Price (Date) | Mar 10, 2025 | |||
| 52-Week High Price (Date) | Mar 12, 2024 | |||
| Valuation | NDRA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 1.85M | |||
| Enterprise Value | -2.45M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -152.52 | |||
| Earnings Per Share Growth | -- | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | 0.28 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $3.57 | |||
| Enterprise Value/EBITDA (TTM) | 0.31 | |||
| Enterprise Value/EBIT | 0.31 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | NDRA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 246.80K | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | NDRA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 734 335 0468 | |||
| Address | 3600 Green Court Ann Arbor, MI 48105-1570 | |||
| Website | endrainc.com | |||
| Country | United States | |||
| Year Founded | 2007 | |||
| Profitability | NDRA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | NDRA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -62.40% | |||
| Return on Equity | -- | |||
| Income Statement | NDRA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -7.92M | |||
| EBIT (TTM) | -7.98M | |||
| Net Income (TTM) | -8.82M | |||
| Net Income Avl. to Common (TTM) | -8.82M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | 24.08% | |||
| EPS Diluted (TTM) | -152.52 | |||
| EPS Diluted Growth (Q YOY) | -- | |||
| Balance Sheet | NDRA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 4.75M | |||
| Cash Per Share (Q) | $19.23 | |||
| Total Current Assets (Q) | 4.96M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 6.60M | |||
| Current Ratio (Q) | 6.096 | |||
| Book Value Per Share (Q) | $12.35 | |||
| Total Assets (Q) | 8.38M | |||
| Total Current Liabilities (Q) | 814.00K | |||
| Total Debt (Q) | 445.30K | |||
| Total Liabilities (Q) | 1.77M | |||
| Total Common Equity (Q) | 6.60M | |||
| Cash Flow | NDRA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -10.50K | |||
| Cash from Financing (TTM) | 9.48M | |||
| Net Change in Cash (TTM) | 1.41M | |||
| Levered Free Cash Flow (TTM) | -2.78M | |||
| Cash from Operations (TTM) | -8.06M | |||
